UK | pharmaphorum

UK

News

Cancer Research UK earmarks £123m for Scottish R&D

Cancer Research UK (CRUK) has said it will award £123 million ($150 million) in funding over the next seven years to Scotland’s Beatson Institute, which will be renamed th

News

Deal allows UK to rejoin EU's Horizon R&D funding scheme

After years of Brexit-related wrangling, the UK is poised to rejoin the EU's Horizon Europe programme which provides funding for scientific research.

News

Wegovy finally reaches the UK, in 'limited' quantities

Novo Nordisk's sought-after obesity therapy Wegovy has finally reached the UK and can be prescribed by NHS weight management services – but supplies are being carefully co

News

Poll finds UK pharma's rep still high post-COVID

The UK pharma industry saw a spike in public trust and favourability amid the COVID-19 pandemic that, so far, shows little sign of wearing off, according to a new poll.

News

GB first to approve Roche's subcutaneous Tecentriq

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has become the first regulator to approve Roche's subcutaneous (SC) formulation of cancer immunotherapy

News

Ex-UK deputy medical officer Van-Tam takes role at Moderna

Professor Sir Jonathan Van-Tam, one of the key faces in the UK government's COVID-19 response, has taken a job as a senior medical consultant at vaccine developer Moderna.

Cancer Research UK earmarks £123m for Scottish R&D

Deal allows UK to rejoin EU's Horizon R&D funding scheme

Wegovy finally reaches the UK, in 'limited' quantities

Poll finds UK pharma's rep still high post-COVID

GB first to approve Roche's subcutaneous Tecentriq

Ex-UK deputy medical officer Van-Tam takes role at Moderna

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

UK

Editor's Picks